Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia
Ashkan Emadi(University of Maryland, Baltimore), Søren M. Bentzen(University of Wisconsin–Madison), Vu H. Duong(University of Maryland, Baltimore), Mohammad Imran(University of Maryland, Baltimore), Zeba N. Singh(University of Maryland, Baltimore), Danielle Sewell(University of Maryland, Baltimore), Maria R. Baer(University of Maryland, Baltimore), Miriam G. Blitzer(University of Maryland, Baltimore), Erin T. Strovel(University of Maryland, Baltimore), Brandon Carter‐Cooper(University of Maryland, Baltimore), Rena G. Lapidus(University of Maryland, Baltimore), Myoung-Hee Lee(University of Maryland, Baltimore), Stephen Yu(University of Maryland, Baltimore), Isabella van der Merwe(University of Maryland, Baltimore), Jennie Y. Law(University of Maryland, Baltimore), Hongxia Li, Sunita Philip(University of Maryland, Baltimore), Linda Jo Bone Jeng(University of California, San Francisco), Philip C. Amrein(Massachusetts General Hospital), Edward A. Sausville(University of Maryland, Baltimore), Amir T. Fathi(University of Southern California)
Cited by 53
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k